125 related articles for article (PubMed ID: 33181836)
1. Enhanced IL-9 secretion by p66Shc-deficient CLL cells modulates the chemokine landscape of the stromal microenvironment.
Patrussi L; Manganaro N; Capitani N; Ulivieri C; Tatangelo V; Libonati F; Finetti F; Frezzato F; Visentin A; D'Elios MM; Trentin L; Semenzato G; Baldari CT
Blood; 2021 Apr; 137(16):2182-2195. PubMed ID: 33181836
[TBL] [Abstract][Full Text] [Related]
2. Leukemic cell-secreted interleukin-9 suppresses cytotoxic T cell-mediated killing in chronic lymphocytic leukemia.
Boncompagni G; Tatangelo V; Lopresti L; Ulivieri C; Capitani N; Tangredi C; Finetti F; Marotta G; Frezzato F; Visentin A; Ciofini S; Gozzetti A; Bocchia M; Calzada-Fraile D; Martin Cofreces NB; Trentin L; Patrussi L; Baldari CT
Cell Death Dis; 2024 Feb; 15(2):144. PubMed ID: 38360867
[TBL] [Abstract][Full Text] [Related]
3. p66Shc deficiency in the Eμ-TCL1 mouse model of chronic lymphocytic leukemia enhances leukemogenesis by altering the chemokine receptor landscape.
Patrussi L; Capitani N; Ulivieri C; Manganaro N; Granai M; Cattaneo F; Kabanova A; Mundo L; Gobessi S; Frezzato F; Visentin A; Finetti F; Pelicci PG; D'Elios MM; Trentin L; Semenzato G; Leoncini L; Efremov DG; Baldari CT
Haematologica; 2019 Oct; 104(10):2040-2052. PubMed ID: 30819907
[TBL] [Abstract][Full Text] [Related]
4. p66Shc Deficiency in Chronic Lymphocytic Leukemia Promotes Chemokine Receptor Expression Through the ROS-Dependent Inhibition of NF-κB.
Tatangelo V; Boncompagni G; Capitani N; Lopresti L; Manganaro N; Frezzato F; Visentin A; Trentin L; Baldari CT; Patrussi L
Front Oncol; 2022; 12():877495. PubMed ID: 35847884
[TBL] [Abstract][Full Text] [Related]
5. A novel class of oxazepine-based anti-cancer agents induces cell death in primary human CLL cells and efficiently reduces tumor growth in Eμ-TCL1 mice through the JNK/STAT4/p66Shc axis.
Vanni F; Lopresti L; Zurli V; Kabanova A; Cattaneo F; Sicuranza A; Gozzetti A; Gemma S; Zisterer DM; Bocchia M; Campiani G; Baldari CT; Butini S; Ulivieri C
Pharmacol Res; 2021 Dec; 174():105965. PubMed ID: 34732370
[TBL] [Abstract][Full Text] [Related]
6. P66Shc: A Pleiotropic Regulator of B Cell Trafficking and a Gatekeeper in Chronic Lymphocytic Leukemia.
Patrussi L; Capitani N; Baldari CT
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32325830
[TBL] [Abstract][Full Text] [Related]
7. p66Shc deficiency in CLL cells enhances PD-L1 expression and suppresses immune synapse formation.
Lopresti L; Capitani N; Tatangelo V; Tangredi C; Boncompagni G; Frezzato F; Visentin A; Marotta G; Ciofini S; Gozzetti A; Bocchia M; Trentin L; Baldari CT; Patrussi L
Front Cell Dev Biol; 2024; 12():1297116. PubMed ID: 38389706
[No Abstract] [Full Text] [Related]
8. Expression of the p66Shc protein adaptor is regulated by the activator of transcription STAT4 in normal and chronic lymphocytic leukemia B cells.
Cattaneo F; Patrussi L; Capitani N; Frezzato F; D'Elios MM; Trentin L; Semenzato G; Baldari CT
Oncotarget; 2016 Aug; 7(35):57086-57098. PubMed ID: 27494881
[TBL] [Abstract][Full Text] [Related]
9. S1P1 expression is controlled by the pro-oxidant activity of p66Shc and is impaired in B-CLL patients with unfavorable prognosis.
Capitani N; Patrussi L; Trentin L; Lucherini OM; Cannizzaro E; Migliaccio E; Frezzato F; Gattazzo C; Forconi F; Pelicci P; Semenzato G; Baldari CT
Blood; 2012 Nov; 120(22):4391-9. PubMed ID: 23033271
[TBL] [Abstract][Full Text] [Related]
10. Absence of caveolin-1 leads to delayed development of chronic lymphocytic leukemia in Eμ-TCL1 mouse model.
Shukla A; Cutucache CE; Sutton GL; Pitner MA; Rai K; Rai S; Opavsky R; Swanson PC; Joshi SS
Exp Hematol; 2016 Jan; 44(1):30-7.e1. PubMed ID: 26435347
[TBL] [Abstract][Full Text] [Related]
11. p66Shc deficiency enhances CXCR4 and CCR7 recycling in CLL B cells by facilitating their dephosphorylation-dependent release from β-arrestin at early endosomes.
Patrussi L; Capitani N; Cattaneo F; Manganaro N; Gamberucci A; Frezzato F; Martini V; Visentin A; Pelicci PG; D'Elios MM; Trentin L; Semenzato G; Baldari CT
Oncogene; 2018 Mar; 37(11):1534-1550. PubMed ID: 29326436
[TBL] [Abstract][Full Text] [Related]
12. Impaired expression of p66Shc, a novel regulator of B-cell survival, in chronic lymphocytic leukemia.
Capitani N; Lucherini OM; Sozzi E; Ferro M; Giommoni N; Finetti F; De Falco G; Cencini E; Raspadori D; Pelicci PG; Lauria F; Forconi F; Baldari CT
Blood; 2010 May; 115(18):3726-36. PubMed ID: 20061561
[TBL] [Abstract][Full Text] [Related]
13. Regulatory T cells contribute to the immunosuppressive phenotype of neutrophils in a mouse model of chronic lymphocytic leukemia.
Goral A; Sledz M; Manda-Handzlik A; Cieloch A; Wojciechowska A; Lachota M; Mroczek A; Demkow U; Zagozdzon R; Matusik K; Wachowska M; Muchowicz A
Exp Hematol Oncol; 2023 Oct; 12(1):89. PubMed ID: 37817276
[TBL] [Abstract][Full Text] [Related]
14. HS1 has a central role in the trafficking and homing of leukemic B cells.
Scielzo C; Bertilaccio MT; Simonetti G; Dagklis A; ten Hacken E; Fazi C; Muzio M; Caiolfa V; Kitamura D; Restuccia U; Bachi A; Rocchi M; Ponzoni M; Ghia P; Caligaris-Cappio F
Blood; 2010 Nov; 116(18):3537-46. PubMed ID: 20530793
[TBL] [Abstract][Full Text] [Related]
15. HDAC6 Inhibition Alleviates CLL-Induced T-Cell Dysfunction and Enhances Immune Checkpoint Blockade Efficacy in the Eμ-TCL1 Model.
Maharaj K; Powers JJ; Mediavilla-Varela M; Achille A; Gamal W; Quayle S; Jones SS; Sahakian E; Pinilla-Ibarz J
Front Immunol; 2020; 11():590072. PubMed ID: 33329575
[TBL] [Abstract][Full Text] [Related]
16. Delayed development of chronic lymphocytic leukemia in the absence of macrophage migration inhibitory factor.
Reinart N; Nguyen PH; Boucas J; Rosen N; Kvasnicka HM; Heukamp L; Rudolph C; Ristovska V; Velmans T; Mueller C; Reiners KS; von Strandmann EP; Krause G; Montesinos-Rongen M; Schlegelberger B; Herling M; Hallek M; Fingerle-Rowson G
Blood; 2013 Jan; 121(5):812-21. PubMed ID: 23118218
[TBL] [Abstract][Full Text] [Related]
17. Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia.
Buchner M; Baer C; Prinz G; Dierks C; Burger M; Zenz T; Stilgenbauer S; Jumaa H; Veelken H; Zirlik K
Blood; 2010 Jun; 115(22):4497-506. PubMed ID: 20335218
[TBL] [Abstract][Full Text] [Related]
18. Dissecting the Prognostic Significance and Functional Role of Progranulin in Chronic Lymphocytic Leukemia.
Schulze-Edinghausen L; Dürr C; Öztürk S; Zucknick M; Benner A; Kalter V; Ohl S; Close V; Wuchter P; Stilgenbauer S; Lichter P; Seiffert M
Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31200555
[TBL] [Abstract][Full Text] [Related]
19. Chemotactic Cues for NOTCH1-Dependent Leukemia.
Piovan E; Tosello V; Amadori A; Zanovello P
Front Immunol; 2018; 9():633. PubMed ID: 29666622
[TBL] [Abstract][Full Text] [Related]
20. CD44 regulates the apoptotic response and promotes disease development in chronic lymphocytic leukemia.
Fedorchenko O; Stiefelhagen M; Peer-Zada AA; Barthel R; Mayer P; Eckei L; Breuer A; Crispatzu G; Rosen N; Landwehr T; Lilienthal N; Möllmann M; Montesinos-Rongen M; Heukamp L; Dürig J; Hallek M; Fingerle-Rowson G; Herling M
Blood; 2013 May; 121(20):4126-36. PubMed ID: 23547049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
